Severity | Placebo n = 558 | 300 mg Group, n = 551 | 450 mg Group, n = 554 | 600 mg Group, n = 564 |
---|---|---|---|---|
Mild | ||||
Percentage | 26.88 | 27.77 | 34.30 | 32.62 |
Difference from placebo (95% CI) | — | 0.89 (−4.37; 6.14) | 7.42 (2.17; 12.9) | 5.74 (0.44; 11.09) |
Moderate | ||||
Percentage | 32.44 | 36.48 | 35.02 | 34.04 |
Difference from placebo (95% CI) | — | 4.04 (−1.56; 9.66) | 2.58 (−3.05; 8.07) | 1.6 (−3.83; 7.04) |
Severe | ||||
Percentage | 40.68 | 35.75 | 30.69 | 33.33 |
Difference from placebo (95% CI) | — | –4.93 (−10.7; 0.77) | –9.99 (−15.63; −4.47) | –7.35 (−12.96; −1.69) |